ASC 808
Active
Collaborative Arrangements
Governs the accounting for collaborative arrangements where two or more parties jointly control an activity and share risks and rewards.
1
Conceptual Framework Linkage
A middle ground between a customer relationship and a joint venture
Some arrangements between two parties – common in pharmaceutical and biotech co-development deals – involve GENUINE joint operating activity and SHARED commercial risk, but WITHOUT forming a separate legal entity and WITHOUT one party simply being a "customer" of the other. ASC 808 exists to give this genuinely middle-ground arrangement its OWN accounting home, rather than forcing it awkwardly into either revenue recognition (ASC 606) or joint venture/consolidation guidance (ASC 810/323).
2
Scope – Two Defining Characteristics
A collaborative arrangement, precisely defined
ASC 808 applies to arrangements involving a JOINT OPERATING ACTIVITY where: (a) the parties are ACTIVE PARTICIPANTS in the activity, and (b) the parties are EXPOSED to SIGNIFICANT RISKS AND REWARDS dependent on the activity's COMMERCIAL SUCCESS – without the arrangement being conducted through a SEPARATE legal entity that one party CONTROLS (which would instead trigger consolidation under ASC 810).
3
Active Participation by Both Parties
Not a passive investment or a simple vendor relationship
"Active participation" means BOTH parties are genuinely INVOLVED in operating decisions – this could include serving on a joint steering committee, sharing in the execution of research or commercialisation activities, or having approval rights over key strategic decisions. This distinguishes a collaborative arrangement from a PASSIVE investment, and from an ordinary vendor-customer relationship where only one party operates the activity.
4
Exposure to Significant Risks and Rewards
Genuine commercial risk sharing
Both parties must be exposed to SIGNIFICANT risks and rewards that depend on whether the underlying activity is COMMERCIALLY SUCCESSFUL – for example, a pharmaceutical co-development arrangement where both parties share in R&D costs AND in eventual product profits (or losses), rather than one party simply receiving a fixed fee regardless of the product's ultimate success.
5
Income Statement Presentation – Not Automatically Revenue
A nuanced classification question
Payments BETWEEN collaborative arrangement participants are generally NOT within ASC 606's scope UNLESS the counterparty is genuinely acting as a "CUSTOMER" for a distinct good or service (see Section 6). Where NOT a customer relationship, the income statement CLASSIFICATION of amounts exchanged (cost reimbursements, profit-sharing payments) is presented based on ANALOGY to other GAAP or a REASONABLE, RATIONAL, and CONSISTENTLY APPLIED accounting policy – often presented as a REDUCTION of the relevant expense category (e.g. netting a cost-sharing reimbursement against R&D expense) rather than as revenue.
6
Interaction With ASC 606
A threshold question determining the accounting model
Some COMPONENTS of a broader collaborative arrangement MAY still fall within ASC 606's scope – for instance, if one party is genuinely acting as a CUSTOMER for a specific, distinct licence or service the other party provides. Assessing whether a given payment stream reflects a customer relationship (governed by ASC 606) or a genuine risk-and-reward sharing arrangement (governed by ASC 808's presentation guidance instead) is often the KEY analytical question in applying this Topic.
7
Worked Example – Cost/Profit-Sharing Presentation
A pharmaceutical co-development arrangement
Example: 50/50 R&D cost sharing with profit split on approval
Two pharmaceutical companies jointly develop a drug candidate, sharing R&D costs 50/50 and agreeing to split eventual product profits 50/50 if approved, with both companies actively participating on a joint development committee. Company A incurs $10,000,000 of R&D costs during the year and receives a $5,000,000 reimbursement from Company B (its 50% share).
Company A recognises the FULL $10,000,000 of R&D expense, and presents the $5,000,000 REIMBURSEMENT received from Company B as a REDUCTION of R&D expense (net R&D expense of $5,000,000) – NOT as revenue, since Company B is not acting as a "customer" here but as a genuine risk-sharing collaboration partner.
8
Disclosure Requirements
What ASC 808 requires
Nature and purpose of the collaborative arrangementRights and obligations of the entity under the arrangementAccounting policy for classifying payments between participants, including the income statement classification chosen and why
9
Critical Judgments & Estimates
Where judgement matters most
The central judgement is determining whether an arrangement genuinely meets BOTH the "active participation" and "significant shared risk/reward" criteria – and, once confirmed as a collaborative arrangement, selecting a REASONABLE, RATIONAL, and CONSISTENT income statement presentation policy for the payments exchanged, since ASC 808 does not prescribe one specific required classification.
10
ASC 808 vs IFRS – No Equivalent Named Category
Comparison – ASC 808 vs IFRS
FeatureUS GAAP (ASC 808)IFRS equivalent
Dedicated middle-ground TopicYes – a specifically named categoryNO equivalent named category – IFRS has no dedicated "collaborative arrangements" standard
How the same fact pattern would be analysedUnder ASC 808's specific presentation guidanceEither as a JOINT ARRANGEMENT under IFRS 11 (if a joint operation/venture structure exists), or under IFRS 15's general customer-relationship principles – without a distinct third category bridging the two
This is one of the clearest examples in the Codification of a genuinely US-specific organisational choice – carving out a dedicated middle-ground category for a common real-world fact pattern (particularly in pharma/biotech) that IFRS instead forces into its existing joint-arrangement or customer-relationship frameworks.
11
Statement Mapping
Where every ASC 808 event lands
EventStatement(s) affectedNotes
Cost-sharing reimbursement receivedISTypically presented as a reduction of the related expense, not revenue
Profit-sharing paymentISClassified per the entity's reasonable, consistent accounting policy
12
Related Topics
Cross-reference map
TopicConnection
ASC 606Applies instead where a party is genuinely acting as a customer for a distinct good/service within the broader arrangement
ASC 323Applies instead if the arrangement is conducted through a separate legal entity with significant influence
ASC 810Applies instead if one party controls a separate legal entity formed for the collaboration
13
Quick-Reference Glossary
Collaborative arrangement
A contractual arrangement involving joint operating activity, active participation by both parties, and exposure to significant risks and rewards dependent on commercial success, without a controlled separate legal entity.
Joint operating activity
An activity conducted jointly by two or more parties without necessarily forming a separate legal entity, the core concept underlying a collaborative arrangement.
Financial statement key
BS Balance sheet
IS Income statement
SE Statement of changes in equity
OCI Other comprehensive income
SCF Statement of cash flows